Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Investing in India and China

This article was originally published in Start Up

Executive Summary

Many life science venture firms are interested in opportunitites in China and India, but few have actually ponied up money.

You may also be interested in...



China’s Top Pharma Firms Prosper; Private Innovators Likely To Lead Sector

Small companies struggle to advance in new, stricter regulatory environment.

Don’t Paint China And India With The Same Opportunity Brush, Speakers Say

China's development track is more "insular" while India is looking to establish a global reach.

Clinical Trial Outsourcing: Germany Is #2; India’s Investigator Ranks Jump 30%

Germany ranks just behind the United States as the go-to place for FDA-regulated clinical trials

Related Content

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

SC091242

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel